CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat Sickle Cell Disease - Rabi Hanna; Haydar Frangoul; Luis Pineiro; Christopher McKinney; Markus Mapara; Jignesh Dalal; Hemalatha G. Rangarajan; Harold Atkins; Akshay Sharma; Kai-Hsin Chang; Michael C. Jaskolka; Keunpyo Kim; et al. (New England Journal of Medicine, 2026)